Search results
BioMarin's (BMRN) Q2 Earnings Top, Voxzogo Drives Sales
Zacks via Yahoo Finance· 2 years agoBioMarin Pharmaceutical BMRN reported second-quarter 2022 adjusted earnings of 59 cents per share,...
BioMarin (BMRN) Q3 Earnings Beat, Sales Miss, Ups Voxzogo View
Zacks via Yahoo Finance· 2 years agoBioMarin Pharmaceutical BMRN reported adjusted earnings of 45 cents per share in third-quarter 2022,...
BioMarin (BMRN) Posts Q4 Earnings Beat, Upbeat Voxzogo Sales
Zacks via Yahoo Finance· 3 months agoBioMarin Pharmaceutical BMRN reported fourth-quarter 2023 adjusted earnings per share of 49 cents,...
5 Stocks Likely to Gain on Q4 Earnings Today After Market Close
Zacks via Yahoo Finance· 3 months agoWe have narrowed our search to five large-cap stocks that are poised to beat on earnings today after...
Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake.
Barrons.com· 2 months agoBARRON'S COVER - MAIN Understanding the products from pharmaceutical companies could be the most...
TG Therapeutics (TGTX) Gets FDA Nod for Multiple Sclerosis Drug
Zacks via Yahoo Finance· 1 year agoThe FDA approves TG Therapeutics' (TGTX) Briumvi (ublituximab-xiiy) for treating relapsing forms of...
BioMarin (BMRN) Q3 Earnings in Line, Sales Miss, '23 View Cut
Zacks via Yahoo Finance· 7 months agoBioMarin's (BMRN) Q3 earnings are in line with estimates but miss the mark on sales. The company...
BioMarin (BMRN) Q4 Earnings Miss, Sales Beat, Stock Down
Zacks via Yahoo Finance· 1 year agoBioMarin (BMRN) reports mixed Q4 results as it misses estimates for earnings but beats the same for...
Biogen says growth is coming, but won’t specify when
BioPharma Dive via Yahoo Finance· 7 months agoCEO Chris Viehbacher said the company has “the elements to think about a return to topline growth.” Yet, that goal hinges on the successful...